Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. Industriels
  2. Médicament
  3. AROLAC (lisuride (maléate de))
  • icone plus
  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte
  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités
Listen Listen
Add to my selection
  • History
  • Technical informations
Share
Share on
Facebook share - facebook.com - new window
Tweeter share - Partager sur Twitter - twitter.com - new window
LinkedIn share - linkedin.com - new window
Print

AROLAC (lisuride (maléate de))

Medicine - Posted on Jun 29 2016 - Updated on Jun 12 2019
Active substance (DCI)
  • lisuride (maléate de)
history (3)
  • 6/8/16

    AROLAC (lisuride (maléate de))

    Maintien du remboursement dans l'inhibition de la montée laiteuse, uniquement en cas de raison médicale ...
    icône flèche
  • 12/16/09

    AROLAC (lisuride (maléate de))

    AROLAC (lisuride (maléate de))
    icône flèche
  • 12/8/04

    AROLAC 0,2 mg, comprimé sécable (boîte de 20)

    AROLAC 0,2 mg, comprimé sécable (boîte de 20)
    icône flèche
Technical information
ATC code
  • G02CB02
Manufacturer
LISAPHARM
Presentation

AROLAC 0,2 mg, comprimé sécable (code CIS : 61674405) - 1 flacon(s) en verre brun de 20 comprimé(s) - Code CIP : 3400933480288

All our publications
    Breast diseases Disorders of adult personality and behaviour Drug therapy Endocrine system diseases Male genital diseases Pregnancy

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
eNq9mF1v2jAUhu/5FVHu8wEtX1Og2li7IbUqo0WbdlOZ5FDMjJ36A+h+/RxCtXRy1NbUu0ycvOfE5/VzjpKc7dbE2wAXmNGB3wxj3wOasgzT+4E/u70Iev7ZsJGs0AZVHuuGcdhs+V5KkBADv1gN54CoCH9cXX4G/T5wf9jwEjZfQSqfPackJuFXJJZXKC+e8ZINw5m3Brlk2cDPldzf9RIhuc5iuGX8l8hRCkl0uFNdXd2dVu8nUSH2ClUlgF8iem8UBWqlmSrOgcoRknDP+KNRepHetXrdThz3rEJgMQXBFE9hguRywtkGZ5CZIyEiwCrIYpvdAN8QkEUQo3i0StfCShyt0G4KD2Nz0h/16kjuZBAHzW672+u3T/rdTie2CsUrW2U2j/6IKM95dtfq907jbicCGiHOCEoDgoXienODNSKgKxpkYFmxCeMSEUe1wmL03HWO4nB4eNETGRY5QY/hSuS2W4U40svANRvcfUjxBbdc04roPftHnypCojdmPTuwxFHGBapGTFFZg5SLqe1GjBiVsKuvqB0F5e7gRQzi/WR/M2ruABM1Jzi1BZ1GkQIhZ9NxPefcI+ITEjDj7hjxHdOMbcX7s6daa0fZ53t8GkV1WZpFXTrNdtv6aP3UxqrpRueKsxwiTSUsjoHNmC7YsZjRXjVLPTnVsUn3AxNLtUjNyBRYcki782nCc+Z/d2erXDCKfjm/tTXNNwX88WZ/aZTG2aBabjtOu4C/dmlt7m/3fHn0XzFPn/ZOWnau5mayLKXMxYco2m634RKJQCC9WeGC/6d+UGnM7mZ8J92/nIZKpjpKfV42y7fVzfYkvjQfHDvzHt4/zNbGGJIrOKIWJbSdoXV8/v60/jvwOkt78gwt7sLsh1MkMaOuxiM1N89Gx/YHXVp6wTUjrhcLXPP3pdaaSVT++Rk2kqj46zNs/AFi7Axh
qENGbKSJ4gE1Yp9x